Performance report of the audit committee in 2021
In 2021, the audit committee under the board of directors of Sansure Biotech Inc(688289) (hereinafter referred to as “the company”) conscientiously performed its audit supervision duties in accordance with the relevant laws and regulations of the CSRC and Shanghai Stock Exchange, the articles of association and the rules of procedure of the audit committee. The performance of the audit committee of the board of directors in 2021 is reported as follows:
1、 Basic information of the audit committee of the board of directors
The audit committee under the board of directors of the company is composed of three members of the board of directors, including independent director Shen Jianlin (accounting professional), independent director Ben Shenglin and chairman Dai Lizhong. Shen Jianlin serves as the convener (Chairman).
2、 Performance of the audit committee of the board of directors in 2021
(I) holding of annual meeting in 2021
In 2021, the audit committee held four meetings, and all members attended the meeting through the combination of on-site and communication. They deliberated and adopted Sansure Biotech Inc(688289) 2020 annual report and summary, Sansure Biotech Inc(688289) proposal on renewing the appointment of 2021 audit institution, Sansure Biotech Inc(688289) 2021 first quarter report There are 5 proposals in total for Sansure Biotech Inc(688289) 2021 semi annual report and summary and Sansure Biotech Inc(688289) 2021 third quarter report.
(II) main work progress
During the reporting period, the audit committee of the board of directors focused on the consideration of important matters such as the preparation of the company’s periodic report. The details are as follows:
1. Review financial reports
The audit committee of the board of directors conscientiously performed the duties entrusted by the board of directors, conducted pre audit on the disclosure of the company’s 2020 annual report and summary, the first quarterly report, semi annual report and third quarterly report of 2021, ensured the scientificity, rationality and effectiveness of the disclosed information, and considered that the periodic report completely reflected the company’s financial situation and operating results during the reporting period, without false records, misleading statements or major omissions, Comply with the requirements of laws and regulations and relevant rules and regulations of the company.
2. Supervise and evaluate the work of external audit institutions
The audit committee of the board of directors supervised and evaluated the annual audit work of the company by China audit Zhonghuan Certified Public Accountants (special general partnership), reviewed its professional competence, investor protection ability, integrity and independence, and considered that the audit institution had good professional quality and followed the professional standards of independence, objectivity and impartiality in financial audit, It reflects the strong professional competence and the ability to perform duties diligently.
3. Guide internal audit
The audit committee of the board of directors carefully reviewed the work plan of the company’s internal audit department, urged it to implement it in strict accordance with the work plan, and put forward guiding opinions on the problems of internal audit. The company’s internal audit and governance level have been improved in an orderly manner, and no major problems have been found in the internal audit work.
3、 Overall evaluation
During the reporting period, the members of the audit committee performed their duties with due diligence, independence, objectivity and impartiality in accordance with relevant regulations, and better completed the work of the audit committee. In 2022, all members will continue to give full play to the supervision function of the audit committee in accordance with the regulatory requirements and the responsibilities and obligations conferred by the company’s system, and earnestly safeguard the common interests of the company and all shareholders.
It is hereby reported.
Sansure Biotech Inc(688289) board of directors audit committee April 18, 2022
